Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 4126820, 10 pages
https://doi.org/10.1155/2017/4126820
Research Article

Reducing Caloric Intake Prevents Ischemic Injury and Myocardial Dysfunction and Affects Anesthetic Cardioprotection in Type 2 Diabetic Rats

1Experimental Laboratory for Vital Signs (ELVIS), Department of Anesthesiology, VU University Medical Center, Amsterdam, Netherlands
2Department of Physiology, VU University Medical Center, Amsterdam, Netherlands

Correspondence should be addressed to Charissa E. van den Brom; ln.cmuv@morbnednav.c

Received 23 August 2016; Accepted 9 February 2017; Published 28 February 2017

Academic Editor: Samy McFarlane

Copyright © 2017 Charissa E. van den Brom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Preis, M. J. Pencina, S.-J. Hwang et al., “Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the framingham heart study,” Circulation, vol. 120, no. 3, pp. 212–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. A. Fleisher, J. A. Beckman, K. A. Brown et al., “ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery),” Circulation, vol. 116, no. 17, pp. e418–e499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. J. Bartness, D. R. Polk, W. R. McGriff, T. G. Youngstrom, and M. DiGirolamo, “Reversal of high-fat diet-induced obesity in female rats,” American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 263, no. 4, pp. R790–R797, 1992. View at Google Scholar · View at Scopus
  4. A. J. Davidoff, M. M. Mason, M. B. Davidson et al., “Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments,” American Journal of Physiology—Endocrinology and Metabolism, vol. 286, no. 5, pp. E718–E724, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. M. Viljanen, A. Karmi, R. Borra et al., “Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults,” The American Journal of Cardiology, vol. 103, no. 12, pp. 1721–1726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Hammer, M. Snel, H. J. Lamb et al., “Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function,” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 1006–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. P. Harkin, P. S. Pagel, J. R. Kersten et al., “Direct negative inotropic and lusitropic effects of sevoflurane,” Anesthesiology, vol. 81, pp. 156–167, 1994. View at Google Scholar
  8. T. P. Malan Jr., J. A. DiNardo, R. J. Isner et al., “Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers,” Anesthesiology, vol. 83, no. 5, pp. 918–928, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Van Den Brom, C. A. Boly, C. S. E. Bulte et al., “Myocardial perfusion and function are distinctly altered by sevoflurane anesthesia in diet-induced prediabetic rats,” Journal of Diabetes Research, vol. 2016, Article ID 5205631, 9 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Bouwman, M. J. A. Vreden, N. Hamdani et al., “Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts,” European Journal of Pharmacology, vol. 647, no. 1-3, pp. 132–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. Lamberts, G. Onderwater, N. Hamdani et al., “Reactive oxygen species-induced stimulation of 5′AMP-activated protein kinase mediates sevoflurane-induced cardioprotection,” Circulation, vol. 120, no. 1, pp. S10–S15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Song, L.-Y. Lv, J. Xu et al., “Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway,” Experimental Biology and Medicine, vol. 236, no. 12, pp. 1427–1436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Huhn, A. Heinen, N. C. Weber, M. W. Hollmann, W. Schlack, and B. Preckel, “Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore,” British Journal of Anaesthesia, vol. 100, no. 4, pp. 465–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Huhn, A. Heinen, M. W. Hollmann, W. Schlack, B. Preckel, and N. C. Weber, “Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 10, pp. 706–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the arrive guidelines for reporting animal research,” PLOS Biology, vol. 8, no. 6, Article ID e1000412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. van den Brom, C. S. E. Bulte, B. M. Kloeze, S. A. Loer, C. Boer, and R. A. Bouwman, “High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study,” Cardiovascular Diabetology, vol. 11, article 74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. E. van den Brom, M. C. Huisman, R. Vlasblom et al., “Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography,” Cardiovascular Diabetology, vol. 8, article 39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Van Dijk, P. A. J. Krijnen, R. A. Vermond et al., “Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction,” Apoptosis, vol. 14, no. 6, pp. 753–763, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P. I. Parekh, A. E. Petro, J. M. Tiller, M. N. Feinglos, and R. S. Surwit, “Reversal of diet-induced obesity and diabetes in C57BL/6J mice,” Metabolism: Clinical and Experimental, vol. 47, no. 9, pp. 1089–1096, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Llado, A. M. Proenza, F. Serra, A. Palou, and A. Pons, “Dietary-induced permanent changes in brown and white adipose tissue composition in rats,” International Journal of Obesity, vol. 15, no. 6, pp. 415–419, 1991. View at Google Scholar · View at Scopus
  21. J. E. Jordan, S. A. Simandle, C. D. Tulbert, D. W. Busija, and A. W. Miller, “Fructose-fed rats are protected against ischemia/reperfusion injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 3, pp. 1007–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Joyeux-Faure, E. Rossini, C. Ribuot, and P. Faure, “Fructose-fed rat hearts are protected against ischemia-reperfusion injury,” Experimental Biology and Medicine, vol. 231, no. 4, pp. 456–462, 2006. View at Google Scholar · View at Scopus
  23. M. S. Mozaffari and S. W. Schaffer, “Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome,” Obesity, vol. 16, no. 10, pp. 2253–2258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Thim, J. F. Bentzon, S. B. Kristiansen et al., “Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome,” Clinical Science, vol. 110, no. 6, pp. 665–671, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. E. F. Du Toit, W. Smith, C. Muller et al., “Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2336–H2343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Morel, C. Berthonneche, S. Tanguy et al., “Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/reperfusion in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 7, pp. 446–451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. E. van den Brom, C. S. E. Bulte, S. A. Loer, R. A. Bouwman, and C. Boer, “Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism,” Cardiovascular Diabetology, vol. 12, article 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Shinmura, K. Tamaki, and R. Bolli, “Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 2, pp. 285–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Hattori, M. Azuma, Y. Gotoh, and M. Kanno, “Negative inotropic effects of halothane, enflurane, and isoflurane in papillary muscles from diabetic rats,” Anesthesia and Analgesia, vol. 66, no. 1, pp. 23–28, 1987. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-S. David, B. Tavernier, J. Amour, B. Vivien, P. Coriat, and B. Riou, “Myocardial effects of halothane and sevoflurane in diabetic rats,” Anesthesiology, vol. 100, no. 5, pp. 1179–1187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Graham, A. Qureshi, R. Noueihed, S. Harrison, and F. C. Howarth, “Effects of halothane, isoflurane, sevoflurane and desflurane on contraction of ventricular myocytes from streptozotocin-induced diabetic rats,” Molecular and Cellular Biochemistry, vol. 261, no. 1, pp. 209–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. P.-H. Lou, E. Lucchinetti, L. Zhang et al., “Loss of Intralipid®—but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signaling,” PLoS ONE, vol. 9, no. 8, Article ID e104971, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. M. Valentijn, W. Galal, E. K. M. Tjeertes, S. E. Hoeks, H. J. Verhagen, and R. J. Stolker, “The obesity paradox in the surgical population,” Surgeon, vol. 11, no. 3, pp. 169–176, 2013. View at Publisher · View at Google Scholar · View at Scopus